Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
DentsplyXRAY |
$15M |
 |
Align TechnologyALGN |
$24M |
 |
NovoCureNVCR |
-$156M |
 |
iRhythm TechnologiesIRTC |
-$885M |
 |
LeMaitre VascularLMAT |
-$1.59B |
Are Femasys Insiders Buying or Selling?
Femasys (FEMY) has had 5 insider transactions in the past 90 days, all buys — insider buying is generally read as a bullish signal. The most recent was Dov Elefant, who bought 15,625 shares at $3.20 on August 7, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the FEMY AI Score. For government officials trading this stock, see FEMY congressional trading.
Recent Femasys Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dov Elefant | Aug 7, 2026 | Buy | 15,625 | $3.2 | $50,000 |
| Kathy Lee-Sepsick | Aug 7, 2026 | Buy | 15,625 | $3.2 | $50,000 |
| Mifek Jeffrey Gerald | Aug 7, 2026 | Buy | 3,125 | $3.2 | $10,000 |
| Sipos Jeremy Alexander | Aug 7, 2026 | Buy | 3,125 | $3.2 | $10,000 |
| Canning John Charles | Aug 7, 2026 | Buy | 4,375 | $3.2 | $14,000 |
Frequently Asked Questions: Femasys Insider Trading
In the past 90 days, Femasys insiders have made 5 buys and 0 sells. The net buying may indicate insider confidence in the company’s outlook.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Lee-Sepsick Kathy has bought the most FEMY stock in the last 2 years, with a total value of $50,000.
According to our estimates, the total value of insider transactions for Femasys in the last 2 years is positive, amounting to $130,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
